Dr. Eric Alexander Secemsky, MD, MS

Dr. Secemsky practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.

Dr. Secemsky's NPI, 1942535489, was assigned on October 15, 2009. Dr. Secemsky graduated from Northwestern University Feinberg Medical School in 2009. Dr. Secemsky holds Massachusetts license 250411.

Dr. Secemsky's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.

Dr. Secemsky's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. Dr. Secemsky is also affiliated with Beth Israel Deaconess Hospital-Needham. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Dr. Secemsky to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Secemsky practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Secemsky's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Secemsky is licensed in Massachusetts.

CMS data shows 522 Medicare services from Dr. Secemsky across 8 procedure codes in 2024, for 311 Medicare patients. Medicare paid $28,784 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 311 Medicare patients who saw Dr. Secemsky in 2024. The largest group is 65 to 74, with 131 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Secemsky's median patient age at 73, with 38% women.

In 2024, Dr. Secemsky wrote 207 Medicare Part D claims for 38 patients. 80% of them were for generic drugs. CMS names the drug for 169 of them, across 9 drugs with 11 or more claims each, at $41,977 in total drug cost. In 2023, CMS named 47 claims across 4 drugs.

Dr. Secemsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Secemsky as offering telehealth. CMS counts 44 procedures of coronary angioplasty and stenting by Dr. Secemsky, more than 80% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 286 papers to Dr. Secemsky, published from 2010 to 2025. 2024 was the busiest year, with 44. The most frequent topics are Peripheral Arterial Disease, Medicare and Endovascular Procedures. Dr. Secemsky has published most often in Vasc Med. Dr. Secemsky's most frequent co-authors are Robert Wayne Yeh, MD, Brett Joseph Carroll, MD and Neel M. Butala, MBA, MD.

Dmand AI links Dr. Secemsky to 1 clinical trial. Conditions studied include Peripheral Arterial Disease and Peripheral Vascular Diseases. Open Payments lists research payments to Dr. Secemsky that name 1 trial.

CMS Open Payments shows 1,064 general payments to Dr. Secemsky from 47 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Boston Scientific Corporation paid the most, $297,910. It also lists 17 research payments totaling $467,640 from 2020 to 2025, naming 1 clinical trial.

Dr. Secemsky graduated from Northwestern University Feinberg Medical School in 2009.